Header
Ihr Suchergebnis
Sie recherchieren derzeit unangemeldet.Melden Sie sich an (Login) um den vollen Funktionsumfang der Datenbank nutzen zu können.
Sie suchen in allen Bereichen nach dem Autor Heitmann M.
In der Rubrik Zeitschriften haben wir 2 Beiträge für Sie gefunden
-
MerkenUse of synthetic data in AI development
Rubrik: IT
(Treffer aus pharmind, Nr. 05, Seite 471 (2024))
Bunzel G | Bertram K | Erdmann N | Heitmann M | Jasper C
Use of synthetic data in AI development / Insights from a case study in Cryo-EM image analysis · Bunzel G1, Bertram K1, Erdmann N2, Heitmann M3, Jasper C4 · 1ATEM SD GmbH, Remscheid und Deloitte Wirtschaftsprüfungsgesellschaft GmbH, Düsseldorf und d-fine GmbH, Frankfurt und Charles River Microbial Solutions Germany GmbH, Kaarst
Unsupervised Machine Learning Synthetic Data Validation Adeno-Associated Viruses (AAV) Cryo-EM Personalized medicine and gene therapy are widely seen as mega trends in the pharmaceutical industry that will revolutionize the industry in the next few years [ 1 ]. One key factor for the success of gene therapy and personalized medicine, has been the use of adeno-associated viruses (AAV) DNA vectors. The AAV process has enabled the development of multiple high-value therapeutics with multi-million revenues per dose, as shown in tab. 1 [ 2 ]. Product Supplier Disease Area Licensed Price ($/dose) Lixturna Spark Therapeutics RPE65 retinal dystrophy 2017 0.85 million Zolgensma Novartis Spinal ...
-
MerkenGood Machine Learning Practices in GxP regulated areas
Rubrik: IT
(Treffer aus pharmind, Nr. 05, Seite 460 (2024))
Stueben J | Heitmann M | Baumann I
Good Machine Learning Practices in GxP regulated areas / An overview on regulatory and industry initiatives · Stueben J1, Heitmann M2, Baumann I3 · 1Boehringer Ingelheim International, Ingelheim, 2d-fine GmbH, Grünwald, 3Thescon GmbH, Coesfeld
With ChatGPT, machine learning has become a mass phenomenon: Within a very short time, the 1 million user mark was exceeded, with just in a few months reaching a user base of 100 million - from private use to writing birthday invitations for children to business use such as chatbots for knowledge management. Even if the application of machine learning methodology is not new, this momentum has led to a substantially higher awareness in the pharmaceutical industry - ranging from enthusiastic to skeptical reactions. At the same time, regulators have launched a number of initiatives dedicated to embedding artificial intelligence ...
